BRIEF-Resverlogix Announces Proposed Offering Of Units

* RESVERLOGIX - OFFERING'S PROCEEDS TO FUND RESEARCH & DEVELOPMENT OF CLINICAL TRIAL ACTIVITIES RELATED TO PHASE 3 BETONMACE TRIAL, AMONG OTHERS Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.